Reliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsorders

Informations projet

S-trodes

N° de convention de subvention: 190162340

DOI

10.3030/190162340

Projet clôturé

Date de signature de la CE 20 Novembre 2023

Date de début 1 Novembre 2023

Date de fin 31 Janvier 2026

Financé au titre de

• The European Innovation Council (EIC)

Coût total

€ 3 672 500,00

Contribution de l’UE

€ 2 457 113,75

Coordonné par

X-TRODES LTD
Israel

Periodic Reporting for period 1 - S-trodes (Reliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsorders)

Période du rapport: 2023-11-01 au 2024-10-31

Résumé du contexte et des objectifs généraux du projet

Sleep disorders are prevalent in one third of the global population, across various age groups, and considered a public health epidemic. Nevertheless, sleep disorders are often unrecognized and under-reported. These disorders can contribute to other medical problems, and some may also be symptoms for underlying mental health issues.
Sleep monitoring is essential for reliable diagnosis and improved management of sleep disorders. Currently, sleep disorders are only measured during an overnight Polysomnography (PSG); however, this method is limited in clinical implication due its unavailability, high cost, unnatural sleep environment and episodic brain patterns. The X-trodes Sleep System (S-trodes), with its Smart Skin technology, will enable monitoring treatment efficacy: replacing conventional PSG with home-based accessible technology.

Travail effectué depuis le début du projet jusqu’à la fin de la période considérée dans le rapport et principaux résultats atteints jusqu’à présent

• X -trodes updated the design of the X-trodes main components, with focus on the Data Aquistion Unit (DAU aka XTR Recording Device) and the Smart Skin Dry electrodes, to optimize their suitability for Sleep tests.
A first batch of the new components, including new Smart Skin patches has been produced and went through verification tests, successfully. These devices will be utilized during the planned clinical validation.
• X-trodes developed algorithms for detection of REM Sleep Without Atonia (RWSA), and Spindles in EEG signals during Sleep tests.
• X-trodes have made significant progress with developing Auto-Scoring algorithms, and we expect to complete and verify the development during 2025.
• In addition, X-trodes moved to a new Cloud platform (Bio-T) to optimize our Web App functionality and usability, in the future, this Cloud platform may facilitate the ability to provide Sleep Report generation and Patient Management to Sleep Health providers.

Progrès au-delà de l’état des connaissances et impact potentiel prévu (y compris l’impact socio-économique et les conséquences sociétales plus larges du projet jusqu’à présent)

• Clinical Data collection and Preliminary laboratory tests have been performed, and the X-trodes Sleep System passed the tests successfully, indicating a possibility to perform the CE submission ahead of time.
• X-trodes developed Data Quality assessment algorithms, that are used to assess the quality of recorded data during a Sleep Test. This Data Quality report is used to troubleshoot and further improve X-trodes electrophysiological signal aquisition technology.
• We have performed studies and published peer reviewed articles on the subject of Sleep monitoring and analysis in a natural setting (See dissemination activities section, items about RWSA and Sleep Spindles)
• X-trodes has secured the endorsement of lead KOLs and advisors in the European Sleep Medicine society:
→ Prof. Dr. Thomas Penzel (President, German Sleep Society), (President-Elect, World Sleep Society), (Director of Interdisciplinary Sleep Medicine Centre, Charité University Hospital, Germany), (Chair of the Sleep Medicine Committee of the ESRS
→ Prof. Dr. Dieter Riemann (JOURNAL OF SLEEP RESEARCH EDITOR), (EUROPEAN INSOMNIA NETWORK (EIN) CHAIR)

Updated XTR Recording device design

Updated XTR Recording device with Sleep Electrodes Patch (Facial EXG7)